Rochem Methotrexate Rochem Methotrexate

X

List of Japan Drug Master File (JDMF) for Tox21_300269 Active Pharmaceutical Ingredient submitted to the Review Authority in Japan (PMDA) and listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

Flag Finland
Digital Content Digital Content
219MF10359
Koivu-Mankkaan tie 6A, FI-02200 Esp...
2018-05-15
2007-12-13
Flag Luxembourg
Digital Content Digital Content
219MF10360
NUERNBERGER STRASSE 12, 90537 FEUCH...
2021-08-19
2007-12-13
Flag China
Digital Content Digital Content
URL Supplier Web Content
220MF10179
West Development Area, Linghu Town,...
2018-03-14
2008-07-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
229MF10125
West Development Area, Linghu Town,...
2017-07-14
2017-07-14
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5MG BASE/ML
  • INJECTABLE;INJECTION - EQ 20MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 25MG BASE/ML
  • INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INJECTION - EQ 50MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)
  • SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)
  • SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)
  • SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)
  • SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)
  • SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)
  • SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)
  • TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Looking for 59-05-2 / Methotrexate API manufacturers, exporters & distributors?

Methotrexate manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Methotrexate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methotrexate manufacturer or Methotrexate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methotrexate manufacturer or Methotrexate supplier.

PharmaCompass also assists you with knowing the Methotrexate API Price utilized in the formulation of products. Methotrexate API Price is not always fixed or binding as the Methotrexate Price is obtained through a variety of data sources. The Methotrexate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Methotrexate

Synonyms

59-05-2, Amethopterin, Rheumatrex, Methylaminopterin, Abitrexate, Trexall

Cas Number

59-05-2

Unique Ingredient Identifier (UNII)

YL5FZ2Y5U1

About Methotrexate

An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.

Tox21_300269 Manufacturers

A Tox21_300269 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_300269, including repackagers and relabelers. The FDA regulates Tox21_300269 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_300269 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tox21_300269 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tox21_300269 Suppliers

A Tox21_300269 supplier is an individual or a company that provides Tox21_300269 active pharmaceutical ingredient (API) or Tox21_300269 finished formulations upon request. The Tox21_300269 suppliers may include Tox21_300269 API manufacturers, exporters, distributors and traders.

click here to find a list of Tox21_300269 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tox21_300269 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Tox21_300269 Drug Master File in Japan (Tox21_300269 JDMF) empowers Tox21_300269 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Tox21_300269 JDMF during the approval evaluation for pharmaceutical products. At the time of Tox21_300269 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Tox21_300269 suppliers with JDMF on PharmaCompass.

Tox21_300269 Manufacturers | Traders | Suppliers

Tox21_300269 Manufacturers, Traders, Suppliers 1
69

We have 3 companies offering Tox21_300269

Get in contact with the supplier of your choice:

  1. Fermion Oy
  2. Fareva
  3. Huzhou Zhanwang Pharmaceutical Co.,Ltd.
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY